The present study aims to characterize the effect of chronic intermittent hypoxia and HIF1α on the non-alcoholic steatohepatitis (NASH) process in mice, and to explore the role of the Treg/Th17 balance in the formation of NASH inflammation and fibrosis. To achieve this purpose, simple steatosis was induced in mice by high-fat diet administration. Subsequently, chronic intermittent hypoxia was simulated by intraperitoneally injecting sodium nitrite. The changes of inflammation, fibrosis, and Treg/Th17 balance in the liver were quantified under chronic intermittent hypoxia condition and after tail vein injection of HIF1α-siRNA. In addition, T cells were cultured in vitro, and HIF1α expression was either blocked or overexpressed under chronic intermittent hypoxia or normal conditions. Then, the changes of Treg/Th17 balance, inflammatory factors, and cell pathways were measured in each group. Our results demonstrated that chronic intermittent hypoxia accelerates the NASH process, while tail vein injection of HIF1α-siRNA improves liver histology and function. Chronic intermittent hypoxia alters the ratio of Th17 and Treg cells through HIF1α and mTOR signaling, and increases the expressions of NF-κB, IL-6, and IL-17, but decreases IL-10 expression. Inhibition of the mTOR-HIF1α-TLR4-IL-6 pathway increases the ratio of Treg/Th17. Thus, chronic intermittent hypoxia modulates the Treg/Th17 balance by inducing HIF1α, resulting in the activation of the mTOR-HIF1α-TLR4-IL-6 pathway, which accelerates the formation of NASH and fibrosis.
Introduction
Non-alcoholic fatty liver disease (NAFLD) is a severe liver disease endangering the Chinese population. NAFLD encompasses a series of pathological states from simple fatty liver and non-alcoholic steatohepatitis (NASH) to hepatic fibrosis and cirrhosis. NASH is the limiting step of NAFLD progressing to liver cirrhosis. The 'second hit' theory suggests that the first hit triggered by insulin resistance enhances the sensitivity of hepatic cells with fatty degeneration to internal and exogenous damage factors and results in inflammation and necrosis, and that the second hit leads to the progression to hepatic fibrosis and cirrhosis [1] .
Previous studies in rodents provided some evidence that Obstructive Sleep Apnea (OSA) and particularly its major adverse consequence, chronic intermittent hypoxia (CIH), are implicated in the pathogenesis and exacerbation of NAFLD. Data in humans also suggested a strong link among OSA, CIH, and NAFLD [2] . Recent studies have revealed that the presence of OSA with or without CIH (the latter reflecting the severity of OSA) exacerbates NAFLD severity and favors the development of NASH [3] [4] [5] .
The severity of OSA is associated with the severity of liver disease, as defined by the presence of NASH or advanced fibrosis [6] . In a cohort of 100 morbidly obese patients with biopsies supporting NAFLD/NASH, a dose response effect of CIH on the exacerbation of NAFLD severity was reported independent of all metabolic confounding factors [7] . Furthermore, CIH is also an independent risk factor for the development of liver fibrosis. A recent study demonstrated that morbidly obese patients with liver fibrosis had higher Apnea Hypopnea Index (AHI) and more severe oxygen desaturation than those without liver fibrosis [8] . Furthermore, in a recent meta-analysis using biopsies of liver fibrosis, OSA patients displayed a 2.6-fold higher risk of liver fibrosis when they also had NAFLD [9] . Therefore, CIH may act as a 'second hit' in the pathogenesis of NAFLD. However, the role of OSA and CIH in the development of NAFLD or the exacerbation of NASH remains to be further tested in humans.
During sustained hypoxia or CIH, transcription factor HIF1α appears to be stabilized and can translocate to the nucleus, bind to DNA, and subsequently induce its target genes [10] . CIH increases the expression of the hypoxia inducible transcription factor HIF1α and those of downstream genes involved in lipogenesis, thereby increasing β-oxidation and consequently exacerbating liver oxidative stress. Previously, we established a simple fatty liver rat model induced by high-fat diet administration for 16 weeks. We then simulated chronic intermittent hypoxia by intraperitoneal injection of nitrite at 20 mg/kg/d for 4 weeks. We demonstrated that chronic intermittent hypoxia induces neovascularization, and accelerates the NASH process and hepatic fibrosis [11] . Recently, a report demonstrated that after feeding Hif1α −/− hep and wild-type mice with a genetically modified high-fat feed for 6 months, hepatic fibrosis and hepatic cell collagen cross-linking were both significantly higher in wild-type mice than in Hif1α −/− hep mice. This suggests that hypoxia up-regulates HIF1α-induced LOX expression and mediates the occurrence of hepatic fibrosis [12] . Treg is regulatory T cell, and Th17 is helper T cell. When the body is under homeostasis or lacking damage due to inflammation, TGFβ1 produced by the immune system inhibits the proliferation of effector T cells and induces the expression of Tregs, thus maintaining the body's immune tolerance. Once infection or inflammation is present, IL-6 is induced, which suppresses the expression of Tregs and induces the differentiation of Th17 cells thus mediating the body's pro-inflammatory response. IL-17 is the main effector molecule of Th17 cells, and effectively mediates inflammatory reactions in tissues. IL-10 inhibits the production of pro-inflammatory cytokines and ameliorates inflammation. Foxp3 is the transcription factor for Tregs, whose expression is suppressed by CIH. RORγt is the transcription factor for Th17, whose expression is promoted by CIH.
Treg deficiency or defects plays an important role in the occurrence and development of NASH. Research on NASH originating from simple fatty liver showed that CD68 + cells and Tregs were significantly increased in liver tissue [13] . However, the Treg number in NAFLD induced by high-fat diet was decreased [14] . Furthermore, some researchers compared the characteristics of T cells in adipose tissue among insulin-resistant obese patients with metabolic abnormalities, metabolically normal insulin-resistant obese patients, and healthy patients, and found that Th17 and Th22 cells in adipose tissue were increased in insulin-resistant obese patients with metabolic abnormalities, leading to the production of cytokines and metabolic dysfunction of the liver [15] . Th17 and IL-17 have an apparent correlation with liver steatosis, the proinflammatory response of NAFLD, which promotes the progress of simple fatty liver to NASH [16] . Therefore, merely investigating the changes of Treg and Th17 in NASH is insufficient to clarify the immune mechanism of NASH. The exact effects of chronic intermittent hypoxia and HIF1α on the balance of Treg/Th17 are still unclear at present. It is assumed that chronic intermittent hypoxia affects the Treg/Th17 balance by up-regulating HIF1α expression, causing inflammation, and promoting the occurrence and development of NASH. In this study, liver simple steatosis was induced in mice by high-fat diet administration, and subsequently chronic intermittent hypoxia was simulated by intraperitoneal injection of nitrite. We quantified the changes of inflammation, fibrosis, and Treg/Th17 balance in livers under hypoxia condition. We also explored the differentiation and function of CD4 + T cells (especially Treg/Th17) regulated by HIF1α through in vitro experiments, and clarified the effects of HIF1α on the progression of NASH, thus providing potential intervention targets for clinical prevention and treatment in the future.
Materials and Methods

Animal model
This study was conducted in accordance with the ethical standards of the Declaration of Helsinki, and approved by the Huzhou Central Hospital Ethics Committee. C57BL/6 mice (18-20 g, 4-6 week-old) were purchased from Sino-British SIPPR/BK Lab Animal Ltd (Shanghai, China) and housed under specific pathogen free (SPF) conditions for 1 week. The mice were fed with a high-fat diet (s3282; Bioserv, San Diego, USA) for 6 weeks to induce NAFLD. NaNO 2 (Shanghai Sangon Biotech, Shanghai, China) was administered to induce chronic hypoxia. HIF1α siRNA (5′-AAGAGGUGGAUAUGUCUGG-3′) was designed and synthesized by Shanghai Sangon Biotech. Thirty mice were randomly divided into five groups (n = 6): group A (control), fed with a normal diet for 10 weeks; group B (hypoxia), fed with a normal diet for 6 weeks followed by 4 weeks of normal diet with intraperitoneal injection of sodium nitrite 30 mg/kg daily; group C (high-fat), fed with a normal high-fat diet for 10 weeks; group D (high-fat + hypoxia), fed with a high-fat diet for 6 weeks followed by 4 weeks of high-fat diet with intraperitoneal injection of sodium nitrite 30 mg/kg daily; and group E (high-fat + hypoxia + HIF1α siRNA), fed with a high-fat diet for 6 weeks followed by 4 weeks of high-fat diet with intraperitoneal injection of sodium nitrite 30 mg/kg daily and with tail vein injection of 40 μg/ml HIF1α-siRNA weekly.
Liver histopathology
The left lobe of the liver was fixed in 4% paraformaldehyde and embedded with paraffin for sectioning. H&E and Masson's trichrome staining were performed on hepatic tissues. According to the guidelines established by the Pathology Committee of NASH Clinical Research Network (NIH, Bethesda, USA), the NAFLD activity (NAS) and hepatic fibrosis scores (FibroS) were obtained. Two investigators from the Pathology Department performed blind reading and scoring [17] .
Lymphocyte isolation
In vivo peripheral lymphocytes were isolated using a lymphocyte isolation kit (Sigma, St Louis, USA) according to manufacturer's instruction. In vitro splenic lymphocytes, a single cell suspension was prepared by pressing the spleen between two slide glasses and then through a 100-gauge stainless steel sieve. 
Biochemical assay
The activities of ALT and AST and levels of TG in murine serum were detected according to the instructions of the commercial kits (Jiancheng Bioengineering Institute, Nanjing, China). Arterial blood was drawn from the femoral arteries cannulated with silicon tubes, and were kept on ice before the determination of the partial pressure of oxygen with a blood gas analyzer (ABL800; Radiometer, Copenhagen, Denmark).
ELISA NF-κB, IL-6, IL-10, and IL-17 levels in mouse liver tissues were detected using the corresponding commercial ELISA kits (Landpia Biotech Co, Shanghai, China) following the manufacturer's instructions. Briefly, 1 g of liver tissue was harvested from each group, homogenized on ice, and treated with lysis buffer (50 mM Tris-HCl, pH 8.0, 150 mM NaCl, and 1% Nonidet P-40). Protein concentration of the lysates was determined by Coomassie blue dye-binding assay (Bio-Rad, Hercules, USA). Samples were added to plates at 1.0 μg/well (50 μl) diluted in PBS. The absorbance of was measured at 450 nm with a microplate reader.
Western blot analysis
Liver protein was isolated from liver tissues in each group as described above. The sample were mixed with 4 × loading buffer to obtain 1 × samples for subsequent analysis, and the samples were boiled for 5 min. Protein samples (100 μg) were resolved by 12% SDS-PAGE and then electroblotted onto PVDF membranes (Bio-Rad). The membranes were blocked for 1 h in blocking buffer and then treated at 4°C overnight with the following primary antibodies: anti-HIF1α antibody (1:300), anti-mTOR antibody (1:500), anti-Foxp3 antibody (1:2000), anti-RORγt antibody (1:1000), anti-β-actin antibody (1:2000) . All antibodies were from Santa Cruz Biotechnology (Santa Cruz, USA), After extensive wash, membranes were incubated with horseradish peroxidase-conjugated anti-mouse IgG (Santa Cruz Biotechnology) and finally detected using ECL kit to visualize the protein bands.
Real-time PCR analysis
For real-time PCR, RNA was extracted from lymphocytes in each group using Trizol reagent (Life Technologies, Carlsbad, USA) according to the manufacturer's instructions. To eliminate residual genomic DNA, the RNA sample was treated with RNase-free DNaseI (TaKaRa, Dalian, China). Purity of the RNA was assessed by spectrophotometry (A260/A280 > 1.8). Single-stranded cDNAs were generated from 1 μg of RNA using PrimeScript first strand cDNA synthesis kit (TaKaRa) according to the manufacturer's instructions. Real-time PCR was performed using SYBR Premix Ex Taq II (Tli RNase H Plus) kit (TaKaRa) according to the manufacturer's protocol. Reaction conditions were 50°C for 2 min; 95°C for 10 min; 40 cycles of 95°C for 30 s, 60°C for 30 s. Relative gene expression was determined by the standard 2 −ΔΔCt method. The expressions of IL-17, IL1β, IL-6, Foxp3, and TGFβ were determined and β-actin was used as an internal control. Sequences of primers used in the real-time PCR were shown in Table 1 .
Statistical analysis
The statistical analyses were performed using SPSS16.0 statistical software package for Windows (IBM, Armonk, USA). Quantitative data are shown as the mean ± SD and analyzed using Student's t-test. P < 0.05 was considered significant.
Results
Chronic intermittent hypoxia was simulated by intraperitoneal injection of sodium nitrite
To determine whether intraperitoneal injection of sodium nitrite leads to chronic hypoxia, changes of blood albumin, methemoglobin, and arterial partial pressure of oxygen were measured following intraperitoneal injection of sodium nitrite (30 mg/kg/d). Results showed that blood albumin was sharply decreased within 0.5 h of injection, and recovered to normal levels after 24 h. While methemoglobin peaked at 0.5 h post-injection, it then gradually declined. The changes of blood albumin and methemoglobin levels within 72 h are shown in Fig. 1A . Furthermore, the rapid rise in methemoglobin was accompanied by reduced arterial partial pressure of oxygen at 0.5 h post-injection. As methemoglobin declined after 2 h, arterial partial pressure of oxygen also gradually recovered to normal levels (Fig. 1B) . Therefore, chronic intermittent hypoxia was simulated by intraperitoneally injecting sodium nitrite.
Chronic intermittent hypoxia promoted the progression of NASH and HIF1α-siRNA treatment ameliorated NASH induced by HFD plus hypoxia
As the causative role of CIH in the exacerbation of NASH remains unclear, we then used the mouse model to detect the effect of CIH and HIF1α on the progression of NASH. In the high-fat group (group C), hepatocyte fatty degeneration and inflammatory cell infiltration were observed by H&E staining, while mild to moderate peri-sinusoid fibrosis or peri-portal fibrosis was demonstrated by Masson staining. In the high-fat + hypoxia group (group D), severe hepatocyte fatty degeneration, aggravated inflammatory cell infiltration, and apparent ballooning degeneration were observed by H&E staining, while peri-sinusoid fibrosis combined with peri-portal fibrosis or bridging fibrosis was seen by Masson staining. In the high-fat + hypoxia + HIF1α siRNA group (group E), inflammatory cell infiltration was significantly alleviated and fibrosis mitigated following HIF1α siRNA treatment ( Fig. 2A-D) . Biochemical examination results demonstrated that TG, ALT, and AST were significantly down-regulated in the high-fat + hypoxia + HIF1α siRNA group (group E) and high-fat group (group C) compared with those in the high-fat + hypoxia group (group D), indicating that the inflammation of hepatic tissue was significantly worse in mice under the combined effects of CIH and high-fat ( Fig. 2E-G) . Details are also summarized in Table 2 .
Hypoxia changed the ratio of Th17 and Treg cells in mouse through the HIF1α and mTOR signaling
As the immunological changes in the effects of CIH and HIF1α on NASH has not been found, so we monitored their impact on the balance of Treg/Th17. Both high-fat diet and CIH led to the reduction of the Treg/Th17 ratio. CIH combined with high-fat diet can further diminish these populations. Treg/Th17 ratio can be increased following HIF1α interference, suggesting that HIF1α plays an important regulatory role in the Treg/Th17 balance in NASH. Details are summarized in Tables 3 and 4 . Flow cytometry analysis suggested that both high-fat diet and CIH decreased the ratio of Treg/Th17. The Treg/Th17 ratio was significantly lower in the high-fat group (group C) compared with that in the control group (group A), and significantly lower in the high-fat + hypoxia group (group D) compared with that in the high-fat group (group C). After HIF1α interference, Treg/Th17 ratio was significantly higher in high-fat + hypoxia + HIF1α siRNA group (group E) compared with that in the high-fat + hypoxia group (group D) (Fig. 3A,B) . The expressions of HIF1α, mTOR, and RORγt proteins were significantly up-regulated, while Foxp3 was decreased under CIH or high-fat conditions as compared to those of the control group (group A). CIH induced the activation of hypoxia responsive pathways such as HIF1α and its upstream transcription factor mTOR. HIF1α, mTOR, and RORγt proteins were slightly increased, while Foxp3 was decreased in highfat + hypoxia group (group D) compared with that in the high-fat group (group C). HIF1α interference also inhibited the development of NAFLD, therefore the expressions of HIF1α, mTOR, and RORγt proteins in high-fat + hypoxia + HIF1α siRNA group (group E) were decreased, while Foxp3 was increased compared with that in high-fat + hypoxia group (group D) (Fig. 3C) . The activation of NF-κB often leads to the occurrence of NASH under hypoxic condition. The expression levels of NF-κB, IL-6, and IL-17 were all significantly down-regulated, while IL-10 was significantly up-regulated in the control group (group A), high-fat + hypoxia + HIF1α siRNA group (group E), and high-fat group (group C) compared with that in the high-fat + hypoxia group (group D). The expression levels of NF-κB, IL-6, and IL-17 were increased, while IL-10 was down-regulated in the hypoxia group (group B), high-fat + hypoxia group (group D), and high-fat group (group C) due to hypoxia or HIF1α activation. HIF1α interference in high-fat + hypoxia + HIF1α siRNA group (group E) inhibited HIF1α activation, thus resulting in the Figure 1 . Chronic intermittent hypoxia is simulated by intraperitoneal injection of sodium nitrite Changes in blood albumin, methemoglobin, and arterial partial pressure of oxygen following intraperitoneal injection of sodium nitrite. Methemoglobin and hemoglobin were measured using commercial kits and arterial oxygen pressure was detected on the blood gas analyzer following intraperitoneal injection of sodium nitrite (30 mg/kg/d). The changes in hemoglobin and methemoglobin levels (A) and arterial oxygen pressure (B) were shown.
down-regulation of NF-κB, IL-6, and IL-17, and up-regulation of IL-10 ( Fig. 3D-G) .
Hypoxia altered the ratio of Treg/Th17 in vitro
In vivo experiments showed that CIH can accelerate the development of NASH induced by high-fat diet, and blocking HIF1α can improve the pathological status of NASH. CIH in vivo can regulate the Treg/Th17 ratio by altering HIF1α and mTOR, but whether hypoxia in vitro can induce the differentiation of Th17 and Treg, as well as their balance is not clear. Flow cytometric quantification of Treg/Th17 demonstrated that Treg/Th17 ratio was markedly increased following HIF1α interference compared with that in the 21% oxygen + control siRNA group, while significantly decreased following HIF1α over-expression compared with that in the 21% oxygen + control plasmid group. Furthermore, Treg/Th17 ratio was significantly lower in the 1% oxygen groups compared with that in the 21% oxygen groups (Fig. 4A,B) . Hypoxic environments can cause the reduction in Treg/Th17 ratio, and promote inflammation, while HIF1α interference can increase the Treg/Th17 ratio, favoring Figure 2 . Chronic intermittent hypoxia promotes the progression of NASH and HIF1α-siRNA treatment ameliorates NASH induced by HFD plus hypoxia Liver sections were stained by H&E (A) and Masson (B). NAS score (C), Fibrosis score (D) and TG (E), ALT (F), and AST (G) in five groups were shown. Characteristic pathological changes of NASH including severe hepatocyte fatty degeneration, aggravated inflammatory cell infiltration, and apparent ballooning degeneration, peri-sinusoid fibrosis combined with peri-portal fibrosis or bridging fibrosis was seen in the high-fat + hypoxia group, while in the high-fat + hypoxia + HIF1α siRNA group inflammatory cell infiltration was significantly alleviated and fibrosis mitigated following HIF1α siRNA treatment. TG, ALT, and AST were significantly down-regulated in the high-fat + hypoxia + HIF1α siRNA group compared with those in the high-fat + hypoxia group (***P < 0.001, **P < 0.01, *P < 0.05).
the amelioration of inflammation. Comparison of the mRNA levels of inflammatory factors revealed that hypoxia promotes inflammation, while blocking HIF1α ameliorates inflammation. IL-17, IL-6, and IL1β mRNAs were down-regulated following HIF1α interference when compared with the 21% oxygen + control siRNA group, while significantly up-regulated following HIF1α over-expression compared with the 21% oxygen + control plasmid group. IL-17, IL-6, and IL1β mRNAs were also significantly higher in the 1% oxygen group compared with the 21% oxygen group (Fig. 4C-E ). Foxp3 and TGFβ mRNAs were strongly up-regulated following HIF1α interference when compared with the 21% oxygen + control siRNA group, while significantly down-regulated following HIF1α over-expression when compared with the 21% oxygen + control plasmid group. Foxp3 and TGFβ mRNAs were significantly lower in the 1% oxygen group compared with those in the 21% oxygen group (Fig. 4F,G) . Hypoxia promotes the expressions of TLR4, IL-6, and HIF1α proteins; while HIF1α interference down-regulates these expressions. Comparison of the expression levels among different groups revealed that TLR4, IL-6, and HIF1α proteins were down-regulated following HIF1α interference when compared with those in the 21% oxygen + control siRNA group, while significantly up-regulated following HIF1α over-expression treatment when compared with those in the 21% oxygen + control plasmid group. TLR4, IL-6, and HIF1α proteins were increased in the 1% oxygen groups compared with those in the 21% oxygen group (Fig. 4H) .
Inhibition of mTOR-HIF1α-TLR4-IL-6 pathway increased the ratio of Treg/Th17
In vitro experiments showed that hypoxia could induce the differentiation of Treg and Th17, change the ratio of Treg/Th17, and affect the expressions of HIF1, TLR4, and IL-6. Whether the cell pathway is involved? Hypoxia causes the reduction in Treg/Th17 ratio and promotes inflammation, while anti-TLR4 monoclonal antibody, anti-IL-6 monoclonal antibody, and mTOR interference (rapamycin) can increase the ratio of Treg/Th17, favoring the amelioration of inflammation. Flow cytometry analysis suggested that the ratio of Treg/Th17 was significantly lower following hypoxic treatment when compared with those in the 21% oxygen groups. Treg/Th17 ratio was higher after anti-TLR4 monoclonal antibody, anti-IL-6 monoclonal antibody, or mTOR interference treatment when compared with that in the 1% oxygen group (Fig. 5A,B) . The mRNA and protein levels of IL-17 were significantly up-regulated following hypoxia treatment when compared with those in the 21% oxygen group. However, following anti-TLR4 monoclonal antibody, anti-IL-6 monoclonal antibody, or mTOR interference treatment, IL-17 was suppressed compared with the 1% oxygen group (Fig. 5C,D) . The mRNA and protein levels of Foxp3 were significantly downregulated following hypoxia treatment when compared with those in the 21% oxygen group. However, following anti-TLR4 monoclonal antibody, anti-IL-6 monoclonal antibody, or mTOR interference treatment, Foxp3 was increased compared with the 1% oxygen group (Fig. 5E) . The mRNA and protein levels of IL-6 were significantly up-regulated following hypoxia treatment when compared with those in the 21% oxygen group. Following treatment with anti-TLR4 monoclonal antibody or mTOR interference treatment, IL-6 was down-regulated, but did not change significantly after anti-IL-6 monoclonal antibody treatment when compared with the 1% oxygen group (Fig. 5F ). The mRNA and protein levels of HIF1α were significantly up-regulated following hypoxia treatment when compared with those in the 21% oxygen group. While no appreciable change was observed following treatment with anti-TLR4 or anti-IL-6 monoclonal antibody, HIF1α was down-regulated following mTOR interference when compared with the 1% oxygen group (Fig. 5G) . The mRNA and protein levels of TLR4 were significantly up-regulated following hypoxia treatment when compared with those in the 21% oxygen group. While no appreciable change was observed following treatment anti-TLR4 or anti-IL-6 monoclonal antibody, TLR4 was significantly downregulated after mTOR interference when compared with the 1% oxygen group (Fig. 5H) .
Discussion
In this study, we demonstrated that chronic intermittent hypoxia induces HIF1α, leads to a Treg/Th17 imbalance, and accelerates NASH progression. We simulated OSA combined with a NAFLD state by intraperitoneal injection of sodium nitrite, and confirmed that CIH accelerates the progression of NAFLD to NASH, aggravates inflammation, and promotes hepatic fibrosis. Blocking HIF1α expression by tail vein injection of HIF1α-siRNA improves the inflammation of NAFLD mice combined with hypoxia. In vivo and in vitro experiments further illuminated that NASH progression is linked to the decline in Treg/Th17 ratio caused by CIH, and that Note: group A (control), B (hypoxia), C (high-fat), D (high-fat + hypoxia), E (high-fat + hypoxia + HIF1α siRNA). 
Group
NAS FibroS
Total score Steatosis Lobular inflammation Ballooning degeneration A 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 B 2.67 ± Note: group A (control), B (hypoxia), C (high-fat), D (high-fat + hypoxia), E (high-fat + hypoxia + HIF1α siRNA).
blocking the mTOR-HIF1α-TLR4-IL-6 pathway increases the Treg/ Th17 ratio and improves inflammation. Currently, the population prevalence of NAFLD in Asia is around 25%, similar to that in many Western countries [18] . However, in 2011 we reviewed the 146 polysomnographyconfirmed moderate to severe OSA patients in our hospital, and found that the percentage of patients who also had NAFLD was as high as 69.2%. Therefore, we hypothesized that CIH may play an important role in the development of NAFLD in the Chinese population.
Previous studies have characterized some possible mechanisms for chronic intermittent hypoxia involvement in the pathogenesis and exacerbation of NAFLD/NASH including: (1) CIH induces metabolic abnormalities, (2) CIH induces gene expression involved in lipogenesis, (3) CIH induces LOX expression, which is involved in extra-cellular matrix rigidity, (4) CIH induces oxidative stress and lipid peroxidation, and (5) CIH induces mitochondrial dysfunction [2] . Our previous studies on rats confirmed that CIH promotes the progression of liver inflammation and fibrosis [11] . Therefore, investigating the specific mechanism by which CIH promotes the progress of hepatic diseases in OSA patients suffering from NAFLD, will provide new therapeutic targets for future treatment.
Tregs have remarkable immunomodulatory activity, with significant effects in regulating the excessive immune response under a variety of pathophysiological conditions. Tregs highly express CD25, and characteristically express the transcription factor Foxp3. Tregs mainly secrete anti-inflammatory factors IL-10 and IL35. Th17 cells, helper T cells differentiated from Th0 cells following stimulation with IL-6 and IL23, mainly secrete pro-inflammatory factors IL-17 and IL22, and characteristically express the transcription factor RORγ.
The relationship between Tregs and Th17 cells is complex, which are mutually antagonized on function but correlated on differentiation. IL-6 mediates the balance of Treg/Th17, inducing the differentiation of naive T cells to Th17 in the presence of TGFβ; however, TGFβ induces the differentiation of Tregs in the absence of IL-6 [19] . Treg/Th17 imbalance can result in the occurrence and development of a variety of autoimmune diseases and tumors [20, 21] . Research on hepatitis B patients suggested that decreased Treg/Th17 ratio is a stimulus for chronic hepatitis B inflammatory injury and liver fibrosis [22] .
Hepatic inflammation is the hallmark of NASH, and the liver immune response plays an important role in the pathogenesis of NASH. Previous studies have demonstrated that Tregs contribute to the pathogenesis of NASH [13] . Increased oxidative stress in a fatty liver leads to apoptosis of Tregs, reduces the number of hepatic Tregs, and leads to a lowered suppression of inflammatory responses. This scenario is likely to be one of the pathogenic mechanisms that facilitate the transformation of simple steatosis into steatohepatitis, following the exposure to a second or third insult [13] .
Secreting anti-inflammatory cytokines such as IL-10, TGFβ, and IL35 is the main mechanism by which Tregs regulate the immune response. Pro-inflammatory factors TNFα and IL-6 are strongly upregulated, while anti-inflammatory factors IL4 and IL-10 are significantly down-regulated in the serum of NASH patients [23] . These findings suggested that Treg deficiency or functional defects in Tregs play an important role in the occurrence and development of NASH. Th17 and IL-17 are also correlated with hepatic steatosis, pro-inflammatory responses to NAFLD [14, 15] . Furthermore, a recent study demonstrated a critical role for polyene phosphatidylcholine capsules in partially attenuating liver inflammatory responses in mice with NAFLD that involves the imbalance of Treg/ Th17 cells and is associated cytokines [24] .
HIF1α targets nearly 100 genes with close associations to hypoxia adaptation, inflammation development, and tumor growth. Under hypoxic conditions, HIF1α may be partially involved in lipid degeneration and inflammatory response [25] . Several research groups have characterized the link between HIF1α and liver fibrosis in animal models [26] [27] [28] . These reports corroborate the idea that tissue hypoxia acts as a 'second hit' and leads to fibrosis in a susceptible liver.
Some studies demonstrated that hypoxia is an intrinsic molecular cue that promotes Foxp3 expression, which in turn elicits potent anti-inflammatory mechanisms to limit tissue damage in conditions of reduced oxygen availability [25] . These mechanisms include (1) hypoxia stimulates Foxp3 transcription through HIF1α, (2) hypoxia enhances the relative Treg abundance in vitro by a TGFβ-dependent mechanism, and (3) T cell intrinsic HIF1α is required for optimal Treg suppressive function [25] .
However, in the synovial fibroblasts of patients with rheumatoid arthritis, HIF1α over-expression promotes the synovial fibroblastsmediated inflammation of Th1 and Th17 cells, leading to the generation of pro-inflammatory factors IL-17 and IFNγ [29] . Recent studies have also shown that HIF1α is key to the production of proinflammatory Th17 cells, and can limit Treg differentiation, thus be an important regulatory factor in maintaining the balance of Treg/Th17 [30, 31] . Previously, we demonstrated that CIH promotes the development and progression of NAFLD, and promotes the progression of simple fatty liver to NASH and fibrosis in rats [10] . In the present study, we confirmed that CIH promotes the progression of simple fatty liver to NASH in mice, and that this progression is linked to HIF1α activation and Treg/Th17 imbalance, resulting in the imbalance of pro-inflammation factors (IL-6 and IL-17) and anti-inflammatory factor (IL-10). However, the specific pathway is still unclear; therefore, we explored the relationship between TLR4, HIF1α, and NASH in an effort to elucidate the mechanism [32] . NAFLD patients often have low level of chronic inflammation, characterized by higher inflammatory factor in blood circulation and inflammatory cell infiltration in local tissue organs. The persistent existence of this inflammation eventually leads to metabolic disorder and dysfunction. Evidence demonstrates that TLR4-induced Note: group A (control), B (hypoxia), C (high-fat), D (high-fat + hypoxia), E (high-fat + hypoxia + HIF1α siRNA).
innate immunity and noninfectious inflammatory responses plays a critical role in the cardiovascular, respiratory, and hepatic systems [33] . TLR4 interacts with endotoxin, directly activates transcription factors NF-κB and AP-1, and induces the transcription of proinflammatory cytokines, including TNFα, IL-6, IL-10, and IL8 [34] .
Aside from endotoxin, saturated fatty acids can also be recognized by TLR4 on macrophages and adipocytes, which is an important mechanism of lipids implicated in regulating the inflammatory reaction and innate immune response [35] . Multiple studies have reported significantly up-regulated TLR4 in rat NASH model, Figure 3 . Hypoxia changes the ratio of Th17 and Treg cells in mouse through HIF1α and mTOR signaling Treg/Th17 ratio was detected by flow cytometry (A,B) and expressions of HIF1α, mTOR, Foxp3, RORγt proteins were detected by western blot analysis (C). Levels of IL-6, NF-κB, IL-17, and IL-10 in groups were measured, respectively (D-G). Treg/Th17 ratio was significantly lower in the high-fat + hypoxia group compared with that in the high-fat group, while following HIF1α interference, it was significantly higher in the high-fat + hypoxia + HIF1α siRNA group compared with that in the high-fat + hypoxia group. HIF1α, mTOR, and RORγt proteins and levels of NF-κB, IL-6, IL-17 were slightly increased, while Foxp3 and IL-10 were down-regulated in the high-fat + hypoxia group compared with those in the high-fat group. HIF1α interference in the high-fat + hypoxia + HIF1α siRNA group inhibited HIF1α activation, thus these protein expressions were decreased and similar to the control group, resulting in the down-regulation of NF-κB, IL-6, and IL-17, and up-regulation of IL-10 (***P < 0.001, **P < 0.01, *P < 0.05).
suggesting that TLR4 is involved in the inflammation and fibrosis of NASH, and leads to the involvement of pro-inflammatory factors in the inflammation and fibrosis progress of NAFLD in a MyD88-dependent manner [36] [37] [38] . Recently, a study from Korea indicated that CIH induces liver fibrosis in DIO mice, and that this phenomenon is associated with TLR4-mediated MAPK and NF-κB signaling. This suggests that TLR4 is associated with the pathogenesis of liver fibrosis in CIH; TLR4 inhibition might thus be a strategy for preventing hepatic fibrosis in patients with OSA [39] . In this study, blocking mTOR-HIF1α-TLR4-IL-6 improves the Treg/Th17 balance, favoring the suppression of the development of NASH. Nevertheless, there are some defects in this study. Firstly, in the in vitro experiment, fibrosis was exacerbated in high-fat + hypoxia group (group D) compared with high-fat group (group C), but not significantly. This might be due to insufficient duration of high-fat diet administration, or inappropriate induction time of CIH. Secondly, intravenous tail injection of control siRNA was ignored as the control for in vitro experiment. Thirdly, this study illustrates the phenomenon from both an in vivo and in vitro perspective, but lacks thorough discussion of specific mechanisms. A mechanistic study with NASH patients will be carried out in the future.
In summary, we demonstrated that chronic intermittent hypoxia could adjust the Treg/Th17 balance by inducing HIF1α, causing the activation of mTOR-HIF1α-TLR4-IL-6 inflammation pathway, and accelerating the formation of NASH inflammation and fibrosis. , and TGFβ in groups were measured, respectively (C-G). TLR4, IL-6, and HIF1α proteins were detected by western blot analysis (H). siRNAs or plasmids were added into CD4 + T cells cultured in normoxic (21% O 2 ) for 24 h, then transferred into hypoxia (1% O 2 ) or normoxia (21% O 2 ) for another 48 h. Hypoxic environments can cause the reduction in Treg/Th17 ratio, and promote inflammation, while HIF1α interference can increase Treg/Th17 ratio, favoring the amelioration of inflammation (**P < 0.01, *P < 0.05). Figure 5 . Inhibition of mTOR-HIF1α-TLR4-IL-6 pathway increases the ratio of Treg/Th17 Treg/Th17 ratio was detected by flow cytometry (A,B) and expressions of TLR4, IL-6, HIF1α, IL-17, and Foxp3 proteins were detected by western blot analysis (C). mRNA levels of IL-17, Foxp3, IL-6, HIF1α, and TLR4 in groups were measured respectively (D-H). siRNAs or plasmids or antibody or rapamycin were added into CD4 + T cells cultured in normoxic (21% O 2 ) for 24 h, then transferred into hypoxia (1% O 2 ) or normoxia (21% O 2 ) for another 48 h. Hypoxia causes the reduction in Treg/Th17 ratio and promotes inflammation, while anti-TLR4 monoclonal antibody, anti-IL-6 monoclonal antibody, and mTOR interference (rapamycin) can increase the ratio of Treg/Th17, favoring the amelioration of inflammation (**P < 0.01).
